Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01391078
Other study ID # Sensimed Triggerfish11/01
Secondary ID
Status Completed
Phase N/A
First received June 14, 2011
Last updated November 27, 2012
Start date June 2011
Est. completion date February 2012

Study information

Verified date November 2012
Source Johannes Gutenberg University Mainz
Contact n/a
Is FDA regulated No
Health authority Germany: Federal Institute for Drugs and Medical Devices
Study type Interventional

Clinical Trial Summary

This prospective, crossover study is designed to correlate SENSIMED Triggerfish® (TF) continuous IOP monitoring with conventional 24 h intraocular pressure profiles in glaucoma patients. There are two control measurements: The GAT/Perkins profile in the same eye in the second night and the GAT/Perkins profile in the same night in the fellow eye. Therefore, each eye serves as test eye and also as control for the second test eye.


Recruitment information / eligibility

Status Completed
Enrollment 12
Est. completion date February 2012
Est. primary completion date January 2012
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patient is able to comply with the study procedure

- Patient must be = 18 years old

- Diagnosis of primary open angle glaucoma (EGS criteria)

- Similar behaviour of IOP in both eyes in former IOP profiles

- Patient has consented to be in the trial and signed informed consent is available before any study related procedures are carried out

- Visual Acuity of 20/200 or better in both eyes

- Ability of subject to understand the character and individual consequences of the study

- For women with childbearing potential, adequate contraception

Exclusion Criteria:

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Intervention

Device:
Sensimed Triggerfish Sensor
IOP will be monitored for 24 hours
Goldmann Applanation Tonometry, Perkins Tonometry
IOP will be measured every two hours within 24 hours

Locations

Country Name City State
Germany Department of Ophthalmology, University Medical Center, Johannes Gutenberg-University Mainz Mainz RLP

Sponsors (2)

Lead Sponsor Collaborator
Katrin Lorenz Sensimed AG

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Relation of GAT/Perkins with TF in a cross-over regression analysis. Correlation of GAT/Perkins values with TF data (mean, min, max, fluctuation) 48 hours No
Secondary Correlation of IOP in the test eye (TF) compared to a conventional 24h IOP profile (GAT) the reference eye (same night) Correlation of GAT/Perkins values with TF data (mean, min, max, fluctuation) 48 hours No
Secondary Correlation of IOP profile (GAT) right versus left eye Correlation of GAT/Perkins values in the right and left eye (mean, min, max, fluctuation) 48 hours No
Secondary Correlation of IOP profile (TF) right versus left eye Correlation of TF data right and left eye (mean, min, max, fluctuation) 48 hours No
Secondary Correlation of IOP with blood pressure Correlation of GAT/Perkins values and TF data with systolic and diastolic blood pressure(mean, min, max, fluctuation) 48 hours No
Secondary Correlation of IOP with heart rate Correlation of GAT/Perkins values and TF data with pulse rate(mean, min, max, fluctuation) 48 hours No
See also
  Status Clinical Trial Phase
Recruiting NCT05564091 - Cataract Surgery in Conjunction With Ab-interno Canaloplasty Compared to Cataract Surgery Only in Patients With Mild to Moderate Primary Open-Angle Glaucoma N/A
Recruiting NCT02792803 - A Comparison of Xalatan (Latanoprost) to Apo-latanoprost and Co-latanoprost in the Treatment of Glaucoma Phase 4
Terminated NCT02801617 - Non-inferiority of PRO-067 Ophthalmic Solution vs GAAP Ofteno® in Glaucoma or Ocular Hypertension Phase 3
Completed NCT01384149 - EXTERNAL SLT Treatment in Patients With Uncontrolled OPEN ANGLE GLAUCOMA Phase 1
Completed NCT00300079 - Study of the Intraocular Pressure (IOP)-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% in Patients With Glaucoma or Ocular Hypertension Phase 4
Enrolling by invitation NCT00221923 - African Descent and Glaucoma Evaluation Study
Recruiting NCT05605743 - Alternate Nostril Breathing Training in Geriatrics With Glaucoma and High Blood Pressure N/A
Completed NCT04828057 - Preservative-free Fixed-dose Combination of Tafluprost 0.0015% / Timolol 0.5% in Patients With Open-angle Glaucoma or Ocular Hypertension: Clinical Effectiveness, Tolerability and Safety in a Real World Setting
Completed NCT01442896 - STudy to Assess Rapid Disease Progression by Clinical and Genetic Factors In Glaucoma patientS That Are High Risk
Enrolling by invitation NCT05557721 - Uddevalla Skövde Transscleral Micropulse Study
Recruiting NCT04595227 - Glaucoma Screening Using Dynamic Analysis of Computerized Pupillary Light Reflex Assessment Device
Terminated NCT04141865 - Effect of Xen Implantation on the Aqueous Humor Proteome
Completed NCT01979913 - An Open, Non-randomized Pilot Study on the Effect of Preservative Free Tafluprost (Saflutan® Augentropfen) in Patients With Ocular Hypertension or Primary Open Angle Glaucoma With an Uncontrolled Intraocular Pressure of 30 mmHg and More Phase 4
Completed NCT01943721 - A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension Phase 1
Not yet recruiting NCT01711177 - Effect of Travoprost 0.004% on Retinal Oximetry in Primary Open Angle Glaucoma N/A
Completed NCT01769521 - Relationship Between 24-hour IOP Pattern and the 24-hour Blood Pressure Pattern in Patients With POAG N/A
Completed NCT02023242 - Comparing Effectiveness of the Hydrus Microstent (TM) to Two iStents to Lower IOP in Phakic Eyes N/A
Recruiting NCT00773877 - Comparison of Retinal Nerve Fiber Layer (RNFL) Thickness Measurements by Time-Domain and Spectral-Domain OCT In Glaucoma Patients N/A
Recruiting NCT00773123 - Efficacy of Retinal Nerve Fiber Layer (RNFL) / Ganglion Cell Layer Thickness Ratio by RT-View Utilizing Spectral -Domain Technology as a Diagnostic Predictor of Glaucoma. N/A
Completed NCT02544646 - Changes in Ocular Rigidity After Trabeculectomy in Patients With POAG N/A